Breast cancer with intraabdominal metastases. Is surgery necessary?
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
http://orcid.org/0000-0003-2703-6030
Iulian Radu
Ionuț Huțanu
Ana-Maria Mușina
Mihaela Buna-Arvinte
Mihaela Mădălina Gavrilescu
Dragoș Viorel Scripcariu
Viorel Scripcariu
Abstract
Metastatic breast cancer has a very poor prognosis, considering the lack of reliable curative medical or surgical approaches. Patients with stage IV breast cancer usually undergo palliative surgical procedures and symptomatic treatment. In a 5-year period, 1258 patients with breast cancer were treated in our surgical oncology unit. For the current study, we have selected 19 (1.43%) female patients with intraabdominal metastases (peritoneal, hepatic, ovarian etc.) derived from breast cancer, which received at least one surgical procedure in our unit. We compared our data with up-to-date reports and guidelines in order to establish the role and further directions of surgery, and (most importantly) the necessity of surgery itself in the management of this therapeutically disadvantaged patient-group. Even if current guidelines do not recommend surgical treatment of intraabdominal metastases derived from breast cancer, several oncology centers (including our unit) did not discard surgery, especially in patients with solitary metastasis.
##plugins.themes.bootstrap3.article.details##
metastatic breast cancer, peritoneal metastases, liver metastases, ovarian metastases, unusual origin metastases, cytoreductive surgery, HIPEC
2. Bertozzi S, Londero A, Cedolini C, Uzzau A, Seriau L, Bernardi S, et al. Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. SpringerPlus 2015; 4(1).
3. National Comprehensive Cancer Network. NCCN Guidelines Insights: Breast Cancer Version 1.2017.
4. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26(suppl 5):v8-v30.
5. Ruiterkamp J, Ernst M. The role of surgery in metastatic breast cancer. Eur J Cancer 2011; 47:S6-S22.
6. Bland KI, Klimberg VS, Copeland EM, Gradishar WJ. The breast: comprehensive management of benign and malignant diseases. Philadelphia, PA: Elsevier; 2018.
7. Barinoff J, Schmidt M, Schneeweiss A, Schoenegg W, Thill M, Keitel S et al. Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery. Eur J Cancer 2017; 83:116-124.
8. Honoré C, Goéré D, Macovei R, Colace L, Benhaim L, Elias D. Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy? J Visc Surg 2016; 153(2):101-107.
9. Abbas H, Erridge S, Sodergren M, Papoulas M, Nawaz A, Menon K et al. Breast cancer liver metastases in a UK tertiary centre: Outcomes following referral to tumour board meeting. Int J Surg 2017; 44:152-159.
10. Mariani P, Servois V, De Rycke Y, Bennett S, Feron J, Almubarak M et al. Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol 2013; 39(12):1377-1383.
11. Bacalbasa N, Balescu I, Dima S, Brasoveanu V, Popescu I. Does re-resection of liver metastases for breast cancer hepatic metastases improve survival? HPB 2016; 18:e187.
12. Garg R, Zahurak M, Trimble E, Armstrong D, Bristow R. Abdominal carcinomatosis in women with a history of breast cancer. Gyn Oncol 2005; 99(1):65-70.
13. Brinkman D, Misra S, Aydin N. A case report of symptomatic gallbladder disease in the setting of peritoneal carcinomatosis originating from invasive lobular carcinoma of the breast. Int J Surg Case Rep 2016; 24:60-62.
14. Cardi M, Sammartino P, Mingarelli V, Sibio S, Accarpio F, Biacchi D et al. Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis. World J Surgical Oncol 2015; 13(1):305-311.
15. Cardi M, Sammartino P, Framarino M, Biacchi D, Cortesi E, Sibio S et al. Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: A preliminary report on 5 cases. Breast 2013; 22(5):845-849.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.